NATROX® Wound Care Announces Vice President of U.S. Sales & Global Marketing

[Cambridge, 21 March 2025] – NATROX® Wound Care, an Inotec AMD company and the leading innovator in continuous topical oxygen therapy (cTOT) for advanced wound care, is pleased to announce the promotion of Nancy Stahulak to Vice President of U.S. Sales & Global Marketing. This strategic appointment underscores the company’s commitment to accelerating growth in the U.S. market and furthering its mission to transform wound healing worldwide.

In her expanded role, Nancy will spearhead both global marketing initiatives and U.S. sales operations, ensuring a cohesive strategy that enhances the adoption of NATROX® O₂, the company’s innovative continuous topical oxygen therapy (cTOT) solution. This leadership enhancement aligns with NATROX Wound Care’s focus of securing national reimbursement and broadening patient access across the U.S.

“Nancy’s exceptional leadership in global marketing has been instrumental in elevating our brand and reaching patients worldwide,” said Craig Kennedy, CEO of NATROX Wound Care. “By integrating U.S. sales under her guidance, we are poised to strengthen our presence in the U.S. market and deliver our transformative wound care solutions to a broader patient population.”

“I am thrilled to take on this expanded position and drive the next phase of growth for NATROX Wound Care. Our mission is to improve patient outcomes through innovation, and I look forward to leading our U.S. sales efforts while continuing to build a strong global marketing presence. By aligning our strategies, we can maximize our impact and ensure more patients have access to the healing power of continuous topical oxygen therapy,” Nancy shared.

This leadership development reflects NATROX Wound Care’s dedication to patient-centric solutions and its mission to transform healing worldwide.

About NATROX® Wound Care, an Inotec AMD Brand
NATROX Wound Care is a pioneering company dedicated to transforming wound care through innovation and a steadfast mission on continuous topical oxygen therapy. Headquartered in Cambridge, UK, the company has developed advanced wound care products like NATROX® O₂, which have been widely recognized for their efficacy and patient benefits. With NATROX O₂’s regulatory approvals in over 25 countries, NATROX Wound Care continues expanding access to innovative wound care solutions globally.

What is NATROX® O₂ Topical Oxygen Therapy
NATROX O₂ is a compact, wearable device which generates and delivers a continuous flow of oxygen directly to the wound bed to promote accelerated healing and foster a healthy wound environment. Its non-invasive nature, coupled with its remarkable effectiveness, offers a significant advancement in chronic wound treatment, even allowing patients to be treated from the comfort of home and experience a renewed quality of life.

To learn more, explore the website: natroxwoundcare.com.